Publications:100
Venetia Zachariou, PhD
About Me
Visit Venetia Zachariou's Laboratory for more information.
Language
English
Position
ADJUNCT PROFESSOR | Neuroscience
Research Topics
Addiction, Behavioral Health, Brain, Depression, Epigenetics, Gene Therapy, Knockout Mice, Membrane Proteins/Channels, Molecular Biology, Neurobiology, Neuroscience, Obesity, Opioid/Cannabinoid Receptors, Pain, Pharmacology, Protein Complexes, Signal Transduction, Spinal Cord, Synaptic Plasticity, Systems Neuroscience, Tolerance, Transcription Factors, Transgenic Mice
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Download the CVResearch
- The function of signal transduction complexes in the striatum in drug addiction
- Regulation of G protein signaling in chronic stress and antidepressant treatment
- Novel intracellular targets for the treatment of chronic pain
- Epigenetic adaptations in neuropathic and inflammatory pain
- The role of the brain reward center in chronic pain and its treatment
Publications
Selected Publications
- HDAC6 inhibition ameliorates sensory hypersensitivity and reduces immune cell signatures in the dorsal root ganglia in murine chronic pain models. Ilinca M. Giosan, Randal A. Serafini, Aarthi Ramakrishnan, Madden J. Tuffy, Jeffrey Zimering, Alexandru Babes, Li Shen, Venetia Zachariou. Molecular Pharmacology
- Nucleus accumbens myocyte enhancer factor 2C mediates the maintenance of peripheral nerve injury–induced physiological and behavioral maladaptations. Randal A. Serafini, Zahra Farzinpour, Vishwendra Patel, Abigail M. Kelley, Molly Estill, Kerri D. Pryce, Farhana Sakloth, Collin D. Teague, Angelica Torres-Berrio, Eric J. Nestler, Li Shen, Schahram Akbarian, Anushree N. Karkhanis, Robert D. Blitzer, Venetia Zachariou. Pain
- tRNA epitranscriptomic alterations associated with opioid-induced reward-seeking and long-term opioid withdrawal in male mice. Jennifer Blaze, Caleb J. Browne, Rita Futamura, Behnam Javidfar, Venetia Zachariou, Eric J. Nestler, Schahram Akbarian. Neuropsychopharmacology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Zachariou has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.